Home › Follicular Lymphoma › Nebraska › Omaha
Follicular Lymphoma clinical trials in Omaha, NE
4 studies for Follicular Lymphoma are looking for participants at sites in and around Omaha (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
RecruitingPhase 1
- Oncology Hematology West, PC dba Nebraska Cancer Specialists, Omaha
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
RecruitingPhase 1/2
- University of Nebraska Medical Center, Omaha
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
RecruitingPhase 1/2
- Oncology Hematology West P.C. dba Nebraska Cancer Specialists, Omaha
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RecruitingObservational study
- Massive Bio SYNERGY-AI site, Omaha
Follicular Lymphoma trials in other cities
- New York City, NY24 studies
- Houston, TX20 studies
- Milwaukee, WI19 studies
- Nashville, TN18 studies
- Baldwin Park, CA16 studies
- Seattle, WA16 studies
- Boston, MA16 studies
- Durham, NC16 studies
- Salt Lake City, UT13 studies
- Columbus, OH13 studies
- Los Angeles, CA13 studies
- Chicago, IL12 studies
Other studies in Omaha
- Prostate Cancer29 studies
- Non-Small Cell Lung Cancer25 studies
- Breast Cancer23 studies
- Cancer (all types)19 studies
- Colorectal Cancer18 studies
- Multiple Myeloma17 studies
- Ovarian Cancer15 studies
- Pancreatic Cancer15 studies
- Head and Neck Squamous Cell Carcinoma15 studies
- Metastatic Cancer14 studies
- Non-Hodgkin Lymphoma14 studies
- Lung Cancer13 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.